ftInvstr
NEPHROPLUS · Healthcare ₹700.0 -0.36% Mkt Cap ₹7025 Cr

NEPHROPLUS

Healthcare Medical Care Facilities
₹700.0
-0.36% today · 30d +1.34%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for NEPHROPLUS. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹282 Cr
NET PROFIT
₹32 Cr
OPM
24.67%
EPS
₹3.19
PE 83.63
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-3.9%, h2=+2.2%, h3=-0.5% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
NEPHROPLUS83.6315.0
APOLLOHOSP62.0325.39
MAXHEALTH65.8915.72
FORTIS63.9415.53
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
66
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
Valuation STRETCHED 20
Growth STRONG 75
Profitability HIGH 78
Technicals NEUTRAL 65
Risk LOW 90
Key Stats
TTM PE
83.63
P/B
6.39
52W HIGH
₹769.75
OFF HIGH
-9.06%
MKT CAP
₹7025 Cr
◉ Active Signals
MACDBullish0.2183
RSI(14)Neutral54.77
Street Consensus
4 analysts
₹822.5
mean target
Low ₹725.0Now ₹700.0High ₹1000.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NEPHROPLUS and at what entry.

Sign up freeSign in